Type 2 Diabetes: Outpatient Insulin Management

Area of Science:

• Endocrinology
• Family Medicine
• Metabolic Diseases

Background:

• Type 2 diabetes affects over 29 million US adults, with 15% requiring insulin therapy.
• Severe hyperglycemia, symptomatic hyperglycemia, or catabolism warrant insulin consideration.
• Optimizing outpatient insulin management is essential for effective type 2 diabetes care.

Purpose of the Study:

• To outline strategies for initiating, titrating, and ensuring adherence to insulin therapy in type 2 diabetes patients within an outpatient setting.
• To guide family physicians in the effective use of insulin for type 2 diabetes management.
• To address challenges and provide recommendations for insulin treatment optimization.

Main Methods:

• Review of current guidelines and evidence for insulin therapy in type 2 diabetes.
• Discussion of preferred insulin regimens, including basal, prandial, and premixed insulin.
• Consideration of insulin titration frequency, use of long-acting insulin analogues, and continuous glucose monitoring.

Main Results:

• Basal insulin with stepwise intensification is the preferred starting regimen.
• Insulin regimens can be titrated every 2-3 days to achieve blood glucose targets.
• Long-acting insulin analogues offer benefits over intermediate-acting insulin regarding duration and hypoglycemia risk.

Conclusions:

• Effective outpatient insulin management requires strategic initiation, titration, and adherence support.
• Individualized glycemic targets considering patient factors are crucial.
• Weight gain, hypoglycemia, and regimen complexity are key challenges requiring careful management.